Akebia Therapeutics Inc - ESG Rating & Company Profile powered by AI
The page is a zero-cost Sustainability report covering Akebia Therapeutics Inc. The Disclosure score includes seventeen United Nations SDGs including: 'Zero Hunger', 'Climate Action' and 'Partnerships for the Goals'. Comprehensive Sustainability assessment of Akebia Therapeutics Inc are reached by signing in.
Akebia Therapeutics Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 2.8; made up of an environmental score of 2.0, social score of 1.6 and governance score of 4.8.
2.8
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1353 | Vera Therapeutics Inc | 2.9 | Medium |
| 1353 | Veracyte Inc | 2.9 | Medium |
| 1393 | Akebia Therapeutics Inc | 2.8 | Medium |
| 1393 | Bioventix PLC | 2.8 | Medium |
| 1393 | Bolt Biotherapeutics Inc | 2.8 | Medium |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Akebia Therapeutics Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Akebia Therapeutics Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Akebia Therapeutics Inc report the average age of the workforce?
Sign up for free to unlockDoes Akebia Therapeutics Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Akebia Therapeutics Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Akebia Therapeutics Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Akebia Therapeutics Inc offer flexible work?
Sign up for free to unlockDoes Akebia Therapeutics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Akebia Therapeutics Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Akebia Therapeutics Inc conduct supply chain audits?
Sign up for free to unlockDoes Akebia Therapeutics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Akebia Therapeutics Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Akebia Therapeutics Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Akebia Therapeutics Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Akebia Therapeutics Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Akebia Therapeutics Inc disclose water use targets?
Sign up for free to unlockDoes Akebia Therapeutics Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Akebia Therapeutics Inc have a product recall in the last two years?
Sign up for free to unlockDoes Akebia Therapeutics Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Akebia Therapeutics Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Akebia Therapeutics Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Akebia Therapeutics Inc disclose parental leave metrics?
Sign up for free to unlockDoes Akebia Therapeutics Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Akebia Therapeutics Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Akebia Therapeutics Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Akebia Therapeutics Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Akebia Therapeutics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Akebia Therapeutics Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Akebia Therapeutics Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Akebia Therapeutics Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Akebia Therapeutics Inc disclose its waste policy?
Sign up for free to unlockDoes Akebia Therapeutics Inc report according to TCFD requirements?
Sign up for free to unlockDoes Akebia Therapeutics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Akebia Therapeutics Inc disclose energy use targets?
Sign up for free to unlockDoes Akebia Therapeutics Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Akebia Therapeutics Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Akebia Therapeutics Inc
These potential risks are based on the size, segment and geographies of the company.
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of renal therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) in dialysis-dependent and non-dialysis dependent adult patients. It also offers Auryxia, a ferric citrate that is used to control the serum phosphorus levels in adult patients with CKD on dialysis; and the treatment of iron deficiency anemia in adult patients with CKD not on dialysis. Akebia Therapeutics, Inc. has collaboration agreements with Otsuka Pharmaceutical Co. Ltd. for the development and commercialization of vadadustat in the United States, the European Union, Russia, China, Australia, Canada, the Middle East, and other countries; and Mitsubishi Tanabe Pharma Corporation for the development and commercialization of vadadustat in Japan and other Asian countries, as well as research and license agreement with Janssen Pharmaceutica NV for the development and commercialization of hypoxia-inducible factor prolyl hydroxylase targeted compounds worldwide. The company was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.